Oncologist Calls for Banning COVID-19 Shots, as Congress Debates Whether They Cause or Accelerate Cancer
British oncologist and immunologist Angus Dalgleish, MD called for a ban of COVID-19 shots in testimony during a U.S. Senate hearing on COVID shot safety on June 3, 2026, citing an observed “marked increase in unexpected cancers among boosted patients.” Heard by the Senate Permanent Subcommittee on Investigations, the subcommittee convened to discuss whether mRNA […]
COVID-19 Inquiry in U.K. Faces Scrutiny and Criticism
The United Kingdom COVID Inquiry has come under renewed criticism following allegations that it failed to publish evidence challenging aspects of the country’s COVID-19 vaccine rollout, while also facing accusations that it endorsed the government’s monitoring and censoring critics of lockdowns. Together, the two controversies have prompted debate over whether the government’s COVID Inquiry has […]
First Trimester COVID-19 Shot Linked to Birth Defects in New Registry Study
A new registry-based cohort study out of Iran published in Sage Journals on June 15, 2026, has found a higher incidence of congenital anomalies, or birth defects, in babies born to women who received a COVID-19 shot within the first trimester of pregnancy compared with those who did not get vaccinated or were vaccinated after […]
‘Vaccines Even More Harmful Than Severe COVID’
I took two doses of Pfizer’s mRNA [COVID] vaccine unaware, at the time, that it was, in fact, a prophylactic gene therapy product and unlike any traditional vaccine. I’m a grieving vaccine injured doctor. I’ve been diagnosed with a persistent autoimmune condition related to loss of bifidobacteria in my gut, and advanced blood tests suggested […]
FDA Panel Backs mFlusiva mRNA Flu Shot for Elderly
Despite a number of significant limitations in the available safety and efficacy data for licensure review of Moderna, Inc.’s new mRNA influenza biologic mFlusiva, the U.S. Food and Drug Administration’s (FDA) Vaccines and Related Biological Products Advisory Committee ((VRBPAC) voted on June 18, 2026 to recommend fast-tracked licensure of the first mRNA product to target […]
FDA Set to Review Moderna’s mFlusiva mRNA Flu Shot
An mRNA (messenger ribonucleic acid) influenza biologic developed by Moderna, Inc. is scheduled to be reviewed today by a U.S. Food and Drug Administration (FDA) advisory panel. The Vaccines and Related Biological Products Advisory Committee ((VRBPAC) will evaluate data on Moderna’s mFlusiva (formerly known as mRNA-1010) to determine if the product provides superior relative vaccine […]